Sio Capital Management’s SkinHealth Systems SKIN Stock Holding History

Sio Capital Management’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-658,964	Closed	-$7.77M	–	55
2022 Q3	$7.77M	Buy	658,964 +296,670	+82%	+$3.75M	2.47%	14
2022 Q2	$4.66M	Buy	+362,294	New	+$4.85M	1.75%	20

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sio Capital Management's SKIN Position: Q4 2022 in Review

Sio Capital Management sold out of SkinHealth Systems (SKIN) in Q4 2022, closing a stake of 658,964 shares — an estimated $7.77M sold.

Sio Capital Management first reported a position in SKIN in Q2 2022 and held it in 2 quarters. The position peaked at $7.77M in Q3 2022. 158 funds tracked by Wall St. Rank hold SKIN as of Q4 2022.

Sio Capital Management reported no remaining SkinHealth Systems position as of Q4 2022 after selling out during the quarter.
Sio Capital Management sold 658,964 SkinHealth Systems shares in Q4 2022, an estimated $7.77M.
Sio Capital Management first reported a position in SkinHealth Systems in Q2 2022 and held it in 2 quarters.
Sio Capital Management's SkinHealth Systems position peaked at $7.77M in Q3 2022.
158 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2022.

Based on Sio Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.